BEGIN:VCALENDAR
PRODID:Bioscientifica
VERSION:1.0
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BiosciProgramme - 
BEGIN:VEVENT
DTSTART:20191111T090000Z
DTEND:20191111T210000Z
UID:f173b338ef1b4097a4b819adff8f74fd
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:REGISTRATION
CATEGORIES:
DESCRIPTION:
CLASS:PUBLIC
LOCATION:
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191111T101500Z
DTEND:20191111T102000Z
UID:9826f6c85dd745ce817b98f988323716
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:WELCOME
CATEGORIES:
DESCRIPTION:
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191111T102000Z
DTEND:20191111T105000Z
UID:c042f118fb414aa19e4d70b178a5bead
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:What Is New
CATEGORIES:
DESCRIPTION:10:20 | WIN1 | What is New in Basic Endocrinology Research\n10:35 | WIN2 | What is New in Clinical Endocrinology Research\n
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191111T110000Z
DTEND:20191111T110500Z
UID:354ccc630dfe4a728d334eab15fad3a9
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:One Minute Silence
CATEGORIES:
DESCRIPTION:
CLASS:PUBLIC
LOCATION:
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191111T110500Z
DTEND:20191111T123500Z
UID:55697fa86c3a41218e255315171790e2
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:How do I…1
CATEGORIES:
DESCRIPTION:11:05 | HDI1.1 | Management of osteoporosis in children and adolescents\n11:20 | HDI1.2 | How do I manage an incidental finding of a thyroid nodule\n11:35 | HDI1.3 | How do I decide which patients with gynaecomastia need more detailed evaluation?\n11:50 | HDI1.4 | How do I manage hair loss and hair growth in PCOS?\n12:05 | HDI1.5 | How do I induce spermatogenesis?\n12:20 | HDI1.6 | How do I choose between weight loss interventions?\n
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191111T110500Z
DTEND:20191111T123500Z
UID:c5ff5eb1619c463f900bd5ae698059a1
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Clinical Management Workshop 1: Salt & Water
CATEGORIES:
DESCRIPTION:11:05 | CMW1.1 | Management of hyponatraemia\n11:35 | CMW1.2 | Diabetes Insipidus - management challenges and pitfalls\n12:05 | CMW1.3 | Co-peptin- a new player in the diagnosis of salt and water balance\n
CLASS:PUBLIC
LOCATION:Syndicate 1 & 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191111T110500Z
DTEND:20191111T123500Z
UID:fdf152c16c294636ad9c174ea89ec447
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Basic Physiology Workshop: Modelling endocrinology in vitro, in vivo & in silico
CATEGORIES:
DESCRIPTION:11:05 | BPW1.1 | In vivo models of endocrinology: new zebrafish models\n11:35 | BPW1.2 | In vitro models of endocrinology: organoids from pituitary and endometrium\n12:05 | BPW1.3 | In silico models of endocrinology: mathematical modelling of endocrine systems\n
CLASS:PUBLIC
LOCATION:Syndicate 3 & 4
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191111T123500Z
DTEND:20191111T135500Z
UID:c66e5d607b1b4b6382c6027a6c6c8d63
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:LUNCH, EXHIBITION, SATELLITES & POSTERS
CATEGORIES:
DESCRIPTION:
CLASS:PUBLIC
LOCATION:Auditorium 1
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191111T124500Z
DTEND:20191111T131500Z
UID:bffc1939c2be47f9b73410a2aadebc04
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Oral Posters 1 - Adrenal and Cardiovascular
CATEGORIES:
DESCRIPTION:12:50 | OP1.1 | Betamethasone/GR ChIP-Seq analysis defines a discrete set of canonical GR homodimer binding sites in primary fetal rat lung mesenchymal fibroblasts\n12:55 | OP1.2 | ABSTRACT WITHDRAWN\n13:00 | OP1.3 | Combining 11C-Metomidate PET/CT and 18F-FDG PET/CT – a new approach to phenotyping indeterminate adrenal lesions\n13:05 | OP1.4 | Global phosphoproteomics links rapidly induced cytoplasmic signals to transcriptional control\n
CLASS:PUBLIC
LOCATION:SfE Theatre
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191111T132000Z
DTEND:20191111T135000Z
UID:3cc6801d644c4cd0aa0afbc6c50d432d
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Oral Posters 2 - Thyroid
CATEGORIES:
DESCRIPTION:13:25 | OP2.1 | Day case radioiodine for remnant ablation in differentiated thyroid cancer patients is safe and helps reduce bed pressures in a busy tertiary centre hospital\n13:30 | OP2.2 | The SH2B3 tryptophan 262 variant is associated with Graves’ disease and Addison’s disease\n13:35 | OP2.3 | Sustained improvements in monitoring and biochemical control of hypothyroidism in primary care with the use of an electronic protocol at two year follow up\n13:40 | OP2.4 | The proto-oncogene PBF mediates Src modulation of radioiodine uptake\n
CLASS:PUBLIC
LOCATION:SfE Theatre
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191111T140000Z
DTEND:20191111T143000Z
UID:86b165bb4fd34d168465c03d7fc32f5a
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Plenary 1:Clinical Endocrinology Trust Lecture 
CATEGORIES:
DESCRIPTION:14:00 | PL1 | Controlling cortisol in cardiometabolic disease\n
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191111T143000Z
DTEND:20191111T150000Z
UID:44f8758199174f879d8217765ef54f7f
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Plenary 2: Society for Endocrinology Starling Medal Lecture
CATEGORIES:
DESCRIPTION:14:30 | PL2 | From its origins to the modern metabolic network\n
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191111T150500Z
DTEND:20191111T163500Z
UID:94d992b3aba24921ade377ae095ee4fd
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Oral Communications 1 - Metabolism and Obesity
CATEGORIES:
DESCRIPTION:15:05 | OC1.1 | Intracrine activation of 11-oxygenated androgens by AKR1C3 modulates lipid metabolism in human female adipose tissue\n15:20 | OC1.2 | Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism\n15:35 | OC1.3 | Metabolic and functional effects of fatty acid overload on in vitro tissue engineered skeletal muscle.\n15:50 | OC1.4 | 5β-reductase (AKR1D1) is downregulated in patients with non-alcoholic fatty liver disease and protects against hepatocellular carcinoma cell proliferation in vitro.\n16:05 | OC1.5 | Prolyl-hydroxylase 3 maintains β-cell glucose-sensing under metabolic stress\n16:20 | OC1.6 | Metabolic surgery reduces kidney SGLT2 expression in mice\n
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191111T150500Z
DTEND:20191111T163500Z
UID:1f0edf3f955540b2b3e0e5473c746258
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Oral Communications 2 - Neuroendocrinology, Pituitary and Neoplasia
CATEGORIES:
DESCRIPTION:15:05 | OC2.1 | Differential effects of subcutaneous pulsatile versus oral hydrocortisone replacement therapy on fMRI resting state and task based emotional processing in Patients with Primary Adrenal insufficiency\n15:20 | OC2.2 | Investigating the role of AIP in pituitary tumourigenesis\n15:35 | OC2.3 | ErbB receptor signalling in MCF7 breast cancer cells: an information theoretic approach\n15:50 | OC2.4 | Investigating the role of vagal Y2R in PYY3-36-mediated appetite suppression\n16:05 | OC2.5 | Efnb2 controls pituitary gland development by regulating proliferation of the pituitary stem/progenitor cells and EMT within the pituitary stem cell niche.\n16:20 | OC2.6 | Post-operative copeptin analysis as a predictor of diabetes insipidus after pituitary surgery\n
CLASS:PUBLIC
LOCATION:Syndicate 1 & 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191111T150500Z
DTEND:20191111T163500Z
UID:4b29ce5c8bdd44b3a83dc621911a8f3d
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Oral Communications 3 - Bone and Calcium
CATEGORIES:
DESCRIPTION:15:05 | OC3.1 | A mouse model generated by CRISPR-Cas9 with a frameshift mutation in the nuclear factor 1/X (NFIX) gene has phenotypic features reported in Marshall-Smith Syndrome (MSS) patients\n15:20 | OC3.2 | Hypophosphatasia in adulthood - are patients really “unaffected”\n15:35 | OC3.3 | Generation of a long acting parathyroid hormone hybrid analogue through fusion to a binding protein\n15:50 | OC3.4 | Characterisation of rare GNA11 variants reveals 8 novel residues important for signalling by the calcium-sensing receptor: Relevance for FHH and ADH\n16:05 | OC3.5 | Mutational analysis of a patient with familial hypocalciuric hypercalcaemia identifies a novel p.Ser182Cys mutation, which is predicted to disrupt the calcium sensing receptor (CaSR) extracellular domain\n16:20 | OC3.6 | The role of biased calcium-sensing receptor signalling in urinary calcium excretion and kidney stone disease\n
CLASS:PUBLIC
LOCATION:Syndicate 3 & 4
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191111T163500Z
DTEND:20191111T170500Z
UID:119aa9073c124c19ab1a68f863438923
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:TEA & COFFEE
CATEGORIES:
DESCRIPTION:
CLASS:PUBLIC
LOCATION:Auditorium 1
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191111T170500Z
DTEND:20191111T180500Z
UID:238c57da8ae34aa1a15ce1252bf015d1
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Innovation Session 1: Advances in understanding skeletal disease
CATEGORIES:
DESCRIPTION:17:05 | IN1.1 | Identifying new skeletal disease\n17:25 | IN1.2 | Hyponatremia and osteoporosis\n17:45 | IN1.3 | Bone fragility in patients with chronic kidney diseases\n
CLASS:PUBLIC
LOCATION:Syndicate 3 & 4
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191111T170500Z
DTEND:20191111T180500Z
UID:909c63b7d4cc40a49b1909921e201a79
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Innovation Session 2: Big data in space and time
CATEGORIES:
DESCRIPTION:17:05 | IN2.1 | Single cell RNA-seq of endocrine organs\n17:35 | IN2.2 | Data Science Approaches to GPCRs and Nuclear Receptors\n
CLASS:PUBLIC
LOCATION:Syndicate 1 & 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191111T170500Z
DTEND:20191111T180500Z
UID:b52c3a9572304b758741a1cc55439863
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Innovation Session 3: NIHR Pathways to clinical impact
CATEGORIES:
DESCRIPTION:17:05 | IN3.1 | From basic science to life changing therapies\n17:25 | IN3.2 | Health Care Professionals, Industry and the NHS: delivering innovation\n17:45 | IN3.3 | Championing Rare Disease Research\n
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191111T181000Z
DTEND:20191111T184000Z
UID:fadb17029b094c5eb9f4e50e08f379ae
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Plenary 3: Society for Endocrinology Dale Medal Lecture
CATEGORIES:
DESCRIPTION:18:10 | PL3 | From Carney complex to gigantism and Cushing disease: an insight in the genetics of pituitary tumors\n
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191111T184000Z
DTEND:20191111T192500Z
UID:76510356d6d642808140579587292dfc
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Debate: Nature vs Nurture
CATEGORIES:
DESCRIPTION:18:40 | D1.1 | AGAINST - This house believes nature not nurture determines our bodyweight\n18:40 | D1.2 | FOR - This house believes nature not nurture determines our bodyweight\n
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191111T192500Z
DTEND:20191111T203000Z
UID:c0f782b9a69e499686d6e72d6d6b23c1
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Presidential Welcome Reception
CATEGORIES:
DESCRIPTION:
CLASS:PUBLIC
LOCATION:
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191112T073000Z
DTEND:20191112T190000Z
UID:fd85df7058664f9a8744bfa805900433
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:REGISTRATION
CATEGORIES:
DESCRIPTION:
CLASS:PUBLIC
LOCATION:
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191112T083000Z
DTEND:20191112T090000Z
UID:2fcbbce5f1ce4829a126bf5712ce7945
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Plenary 4: Society for Endocrinology Transatlantic Medal Lecture
CATEGORIES:
DESCRIPTION:08:30 | PL4 | How is alkaline phosphatase essential for bone? The Transatlantic stories\n
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191112T090000Z
DTEND:20191112T093000Z
UID:0bf0e7f37f4c4cf2a871c5e7dfc193f2
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Plenary 5: Society for Endocrinology International Medal Lecture
CATEGORIES:
DESCRIPTION:09:00 | PL5 | The Melanocortin Microcircuitry and its Role in Energy Homeostasis\n
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191112T093500Z
DTEND:20191112T103500Z
UID:abf252d2c9084d2ea747f0443959e971
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Early Careers and Plenary Orals
CATEGORIES:
DESCRIPTION:09:35 | EC1.1 | Early Career Prize lecture Basic Science\n09:55 | EC1.2 | Early Career Prize lecture Translational\n10:15 | EC1.3 | Urine steroid metabolome analysis allows for metabolic risk stratification in 1309 prospectively recruited patients with benign adrenal tumours and different degrees of cortisol excess\n10:25 | EC1.4 | CET Best Abstract Basic\n
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191112T103500Z
DTEND:20191112T110500Z
UID:ee624273e5be451e911530098ce9bea0
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:TEA & COFFEE
CATEGORIES:
DESCRIPTION:
CLASS:PUBLIC
LOCATION:Auditorium 1
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191112T110500Z
DTEND:20191112T123500Z
UID:641d51c81b5b4f4ca27fc708af2022fd
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Symposium 1: Gut hormones physiology pathology and pharamcology
CATEGORIES:
DESCRIPTION:11:05 | S1.1 | Physiology and pharmacology of gut hormones\n11:35 | S1.2 | Combination of gut hormone therapy\n12:05 | S1.3 | Therapeutic landscape\n
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191112T110500Z
DTEND:20191112T123500Z
UID:03d5d531bba74f53997c57f69b8a0fe8
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Symposium 2: New insights into PCOS 
CATEGORIES:
DESCRIPTION:11:05 | S2.1 | Fetal antecedents of PCOS is there a role of AMH?\n11:35 | S2.2 | PCOS, obesity and energy balance\n12:05 | S2.3 | Origins of obesity in women with PCOS\n
CLASS:PUBLIC
LOCATION:Syndicate 1 & 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191112T110500Z
DTEND:20191112T123500Z
UID:ec2a809c94ad41f9a0004436d9e00681
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Symposium 3: Phosphate homeostasis physiology pathology and pharmacology
CATEGORIES:
DESCRIPTION:11:05 | S3.1 | Advances in FGF23 Signalling\n11:35 | S3.2 | Phosphate Sensing\n12:05 | S3.3 | FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment\n
CLASS:PUBLIC
LOCATION:Syndicate 3 & 4
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191112T110500Z
DTEND:20191112T123500Z
UID:25a788716be64707a303ac95a75b3b0f
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Nurses' session 1: NICE & T3
CATEGORIES:
DESCRIPTION:11:05 | NS1.1 | T3 replacement – What does the evidence suggest?\n11:35 | NS1.2 | The health care professional & patient consultation - Informed decision making\n12:05 | NS1.3 | A Beginners Guide: setting up a Nurse-Led Thyroid Clinic\n
CLASS:PUBLIC
LOCATION:Meeting Room 9
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191112T124000Z
DTEND:20191112T132500Z
UID:a40a18b1df704deabb78fc9c858f564e
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Meet The Expert 1
CATEGORIES:
DESCRIPTION:12:40 | MTE1 | Thyroid disease after immune reconstitution\n
CLASS:PUBLIC
LOCATION:Syndicate 1 & 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191112T124000Z
DTEND:20191112T132500Z
UID:978425a6591c4a3f9dae790a610337d2
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Meet The Expert 2
CATEGORIES:
DESCRIPTION:12:40 | MTE2 | When should I consider functional imaging in adrenocortical disease?\n
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191112T124000Z
DTEND:20191112T132500Z
UID:7c9a66d4b3c14eaab629f651cc1ce02c
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Meet The Expert 3
CATEGORIES:
DESCRIPTION:12:40 | MTE3 | Update on DSD genetics\n
CLASS:PUBLIC
LOCATION:Syndicate 3 & 4
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191112T132500Z
DTEND:20191112T144000Z
UID:8c643794c9c04560a5b73b60d87d6a13
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:LUNCH, EXHIBITION & POSTERS
CATEGORIES:
DESCRIPTION:
CLASS:PUBLIC
LOCATION:Auditorium 1
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191112T133000Z
DTEND:20191112T140000Z
UID:2c013e64014f464885686848d0e5f6bc
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Oral Posters 3 - Metabolism and Obesity
CATEGORIES:
DESCRIPTION:13:35 | OP3.1 | Intermittent cold exposure ameliorates fatty liver disease\n13:40 | OP3.2 | Intestinal injury and evidence of increased gut permeability in female AKR1D1 knockout mice\n13:45 | OP3.3 | The Impact of Subcutaneous Infusions of three Anorexigenic Gut Hormones Glucagon-like Peptide-1, Oxyntomodulin and Peptide YY (GOP) on the Psychological Health of Obese Diabetic Patients.\n13:50 | OP3.4 | Mice with a gain-of function Gα11 mutation have autosomal dominant hypocalcaemia, but not impaired glucose metabolism.\n
CLASS:PUBLIC
LOCATION:SfE Theatre
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191112T140500Z
DTEND:20191112T143500Z
UID:410c0386860b4615a34447959751906a
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Oral Posters 4 - Bone and Calcium
CATEGORIES:
DESCRIPTION:14:10 | OP4.1 | Oral calcium loading test can predict the progression of hypercalcaemic primary hyperparathyroidism in patients with normocalcaemic hyperparathyroidism\n14:15 | OP4.2 | Identification of novel pathogenic variants and phenotypic features in patients with pseudohypoparathyroidism and acrodysostosis, subtypes of the newly defined inactivating PTH/PTHrP signalling disorders (iPPSD) classification system\n14:20 | OP4.3 | Mendelian randomization and machine learning  to assess the causal association of Type 2 Diabetes with osteoporosis and  fragility fractures\n14:25 | OP4.4 | The associations between body fat distribution and bone mineral density in the Oxford Biobank: a cross sectional study\n
CLASS:PUBLIC
LOCATION:SfE Theatre
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191112T144500Z
DTEND:20191112T161500Z
UID:82f17d64303e4fd98705e62dfcf29c01
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Oral Communications 4 - Thyroid
CATEGORIES:
DESCRIPTION:14:45 | OC4.1 | A high-throughput yellow fluorescent protein (YFP) cell-based screen identifies autophagy modulators to increase the effectiveness of radioiodine therapy\n15:00 | OC4.2 | Reduced Length of Hospital Stay with the use of recombinant TSH compared to Thyroid Hormone Withdrawal –A two centre retrospective study\n15:15 | OC4.3 | The disturbed thyroid gland homeostasis in conditions of subacute exposure to thyroid-disrupting chemicals: experimental study in Wistar rats\n15:30 | OC4.4 | Development of auto-immune thyroid dysfunction in multiple sclerosis patients receiving Alemtuzumab is associated with improved response to treatment\n15:45 | OC4.5 | The prevalence of thyroid dysfunction and autoimmunity in women with history of miscarriage or subfertility across the United Kingdom\n16:00 | OC4.6 | Driver events in thyroid cancer recurrence\n
CLASS:PUBLIC
LOCATION:Syndicate 1 & 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191112T144500Z
DTEND:20191112T161500Z
UID:48d6433dbeae47069989da7b84189657
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Oral Communications 5 - Adrenal and Cardiovascular
CATEGORIES:
DESCRIPTION:14:45 | OC5.1 | Central role for corticosteroid-binding globulin in rat HPA axis sexual dimorphism\n15:00 | OC5.2 | Subclinical alpha-1 antitrypsin deficiency is associated with increased free cortisol fraction in plasma\n15:15 | OC5.3 | Common variants in the gene encoding corticosteroid binding globulin influence cortisol-responsive gene networks in human adipose tissue\n15:30 | OC5.4 | Pre-receptor metabolism and signalling of glucocorticoids between macrophages and fibroblasts\n15:45 | OC5.5 | Somatic transmembrane domain mutations of a cell adhesion molecule, CADM1, cause primary aldosteronism by preventing gap junction communication between adrenocortical cells\n16:00 | OC5.6 | SLC35F1, a potential marker for aldosterone producing cell clusters\n
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191112T144500Z
DTEND:20191112T161500Z
UID:8875ed332b3f4cc992053d80536bb682
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Oral Communications 6 - Reproductive Endocrinology and Biology
CATEGORIES:
DESCRIPTION:14:45 | OC6.1 | Effect of MVT-602, a potent kisspeptin receptor agonist, on LH levels in healthy pre-menopausal women undergoing a minimal controlled ovarian stimulation protocol\n15:00 | OC6.2 | Differential follicle stimulating hormone glycosylation modulates follicle growth and survival rates\n15:15 | OC6.3 | Investigating the impact of altered maternal extracellular vesicle miRNAs on placental function in women with gestational diabetes complicated by large for gestational age infants\n15:30 | OC6.4 | Kallmann syndrome-associated WDR11 regulates primordial germ cell development\n15:45 | OC6.5 | Placental expression of estrogen related receptor γ (ERRγ) is hypoxia-sensitive and is altered in pregnancies complicated by fetal growth restriction\n16:00 | OC6.6 | Kisspeptin Enhances the Brain Processing of Attraction in Men\n
CLASS:PUBLIC
LOCATION:Syndicate 3 & 4
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191112T144500Z
DTEND:20191112T161500Z
UID:0f43080834cd40678033f3a9650ffcb7
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Nurses' session 2: Management of Hyper & Hypocalcaemia
CATEGORIES:
DESCRIPTION:14:45 | NS2.1 | Aetiology of hyper and hypocalcaemia\n15:15 | NS2.2 | Patient management of hypercalcaemia & when should the surgeon intervene?\n15:45 | NS2.3 | Patient management of hypocalcaemia & the patient perspective\n
CLASS:PUBLIC
LOCATION:Overflow room (to the left of the Registration desks)
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191112T161500Z
DTEND:20191112T164500Z
UID:276158cc4281446d9420a6e824875bc1
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:TEA & COFFEE
CATEGORIES:
DESCRIPTION:
CLASS:PUBLIC
LOCATION:Auditorium 1
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191112T164500Z
DTEND:20191112T181500Z
UID:4638eb304ec94a6da3b55daab65b6f3d
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Early Careers Symposium: Engaging with the public
CATEGORIES:
DESCRIPTION:16:45 | ECS1.1 | How your Society can help you engage the public\n17:03 | ECS1.2 | Making the best of what you’re given – public engagement grants\n17:21 | ECS1.3 | How to reach out across social media\n17:39 | ECS1.4 | Meaningful engagement with patients: The importance of recognising common humanity in patients is key to improving relationships’\n17:57 | ECS1.5 | Endocrinology in the public eye\n
CLASS:PUBLIC
LOCATION:Syndicate 1 & 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191112T164500Z
DTEND:20191112T181500Z
UID:b8c0e0701ba14008b51c57cde7a4c90e
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:How do I…2
CATEGORIES:
DESCRIPTION:16:45 | HDI2.1 | How do I diagnose cyclical Cushing's\n17:00 | HDI2.2 | How should I manage non-standard thyroid hormone replacement\n17:15 | HDI2.3 | When and how should I start screening for MEN1 in children\n17:30 | HDI2.4 | How do I decide when to initiate dopamine agonist withdrawal\n17:45 | HDI2.5 | How do I… manage therapeutic glucocorticoid withdrawal\n18:00 | HDI2.6 | How do I manage withdrawal of denosumab\n
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191112T164500Z
DTEND:20191112T181500Z
UID:cefa6be7ba2347969d13e37a51d7c005
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Senior Endocrinologists' Session
CATEGORIES:
DESCRIPTION:16:45 | SE1.1 | What happened to the adrenal X-zone?\n17:15 | SE1.2 | Is the estrogenic component of Premarin all bad?\n17:45 | SE1.3 | Potential benefits of better vitamin D status for non-bony disorders?\n
CLASS:PUBLIC
LOCATION:Syndicate 3 & 4
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191112T182000Z
DTEND:20191112T185000Z
UID:d5b8ce8afecf409dbd341f6455f3d38a
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Plenary 6: Society for Endocrinology European Medal Lecture
CATEGORIES:
DESCRIPTION:18:20 | PL6 | Mechanisms and consequences of endocrine autonomy – lessons learned from the adrenal cortex\n
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191112T185000Z
DTEND:20191112T193500Z
UID:42640fea1f8542f885b7a3f9fb4359d3
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Society for Endocrinology AGM - members only
CATEGORIES:
DESCRIPTION:
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T073000Z
DTEND:20191113T173000Z
UID:bffaeb65830046cd97ebe0f703da8de9
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:REGISTRATION
CATEGORIES:
DESCRIPTION:
CLASS:PUBLIC
LOCATION:
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T083000Z
DTEND:20191113T090000Z
UID:b00408b6621c44b09f0ff2a24e331ae2
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Plenary 7: British Thyroid Association Pitt-Rivers Lecture
CATEGORIES:
DESCRIPTION:08:30 | PL7 | Thyroid cancer genomics, differentiation state and response to radioiodine\n
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T090000Z
DTEND:20191113T093000Z
UID:fabbd94046b448ad80f07b89db9f8236
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Plenary 8: CET Visiting Professor Lecture
CATEGORIES:
DESCRIPTION:09:00 | PL8 | Cushing’s syndrome as a model of endocrine tumorigenesis\n
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T093500Z
DTEND:20191113T102000Z
UID:a96d98cfcf124d89a8e763fefa3fccdb
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Clincal Skills: Being a consultant - How to get the job and keep it
CATEGORIES:
DESCRIPTION:09:35 | SK1.1 | How to get the consultant post you want\n09:50 | SK1.2 | How to approach your first job plan - Get it right first time/How to get the job you want\n10:05 | SK1.3 | How do I set up a new service?\n
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T093500Z
DTEND:20191113T102000Z
UID:b3910d22104b4f538355ab4a9f9cf203
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Basic Skills: Introduction to teaching 
CATEGORIES:
DESCRIPTION:09:35 | SK2.1 | Getting started in undergraduate teaching; what, when and how?\n09:57 | SK2.2 | Challenging students and difficult supervisors; how to supervise students effectively when things go wrong. \n
CLASS:PUBLIC
LOCATION:Syndicate 1 & 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T093500Z
DTEND:20191113T102000Z
UID:e6147d1c540246d0921e53b04b402ec0
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Teaching Skills: Innovations in teaching
CATEGORIES:
DESCRIPTION:09:35 | SK3.1 | New approaches to effective teaching\n09:57 | SK3.2 | Innovative teaching exercise\n
CLASS:PUBLIC
LOCATION:Syndicate 3 & 4
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T102000Z
DTEND:20191113T105000Z
UID:b967d16078d4414da16a64333acd533c
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:TEA & COFFEE
CATEGORIES:
DESCRIPTION:
CLASS:PUBLIC
LOCATION:Auditorium 1
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T105000Z
DTEND:20191113T122000Z
UID:0cb82531886b42f1b04e56af37c31da5
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Symposium 4: Thyroid hormone a key regulator in inflammation?
CATEGORIES:
DESCRIPTION:10:50 | S4.1 | Thyroid hormone inhibits lung fibrosis \n11:20 | S4.2 | Thyroid hormone regulation of Inflammation \n11:50 | S4.3 | TED novel agents how they work and how to use them CIRTED MINGO papers\n
CLASS:PUBLIC
LOCATION:Syndicate 1 & 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T105000Z
DTEND:20191113T122000Z
UID:930fc8bd0ab74cf893932133350a26c6
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Symposium 5: Stress – The rhythm of life 
CATEGORIES:
DESCRIPTION:10:50 | S5.1 | The interplay between stress, biological clocks and metabolic function\n11:20 | S5.2 | Dynamic of Adrenal in health and disease\n11:50 | S5.3 | The interplay between sleep and the endocrine system\n
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T105000Z
DTEND:20191113T122000Z
UID:16f4cf014c044daf94ac36bad3d0c9e7
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Symposium 6: New horizons in neuro-endocrine disease
CATEGORIES:
DESCRIPTION:10:50 | S6.1 | Preclinical drug studies for MEN1 NETs\n11:20 | S6.2 | Using genetics to inform on pharmalogical targeting of NETs\n11:50 | S6.3 | Molecular endocrine imaging in occult de novo or recurrent pituitary disease\n
CLASS:PUBLIC
LOCATION:Syndicate 3 & 4
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T122500Z
DTEND:20191113T131000Z
UID:cba5998eb10a47cc9cf8a28fff2db371
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Meet The Expert 4
CATEGORIES:
DESCRIPTION:12:25 | MTE4.1 | Fighting liver fat\n12:47 | MTE4.2 | Fighting liver fat\n
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T122500Z
DTEND:20191113T131000Z
UID:13e3b98429d743aa941991bd0ee947e3
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Meet The Expert 5
CATEGORIES:
DESCRIPTION:12:25 | MTE5 | Novel Epigenetic inhibitors\n
CLASS:PUBLIC
LOCATION:Syndicate 1 & 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T122500Z
DTEND:20191113T131000Z
UID:d5718418d83e4eda871052d0984ba1a6
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Meet The Expert 6
CATEGORIES:
DESCRIPTION:12:25 | MTE6 | What have we learned from HR-pQCT?\n
CLASS:PUBLIC
LOCATION:Syndicate 3 & 4
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T131000Z
DTEND:20191113T142500Z
UID:c0ac4587deba4933a6dc858ed22a01a6
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:LUNCH, EXHIBITION & POSTERS
CATEGORIES:
DESCRIPTION:
CLASS:PUBLIC
LOCATION:Auditorium 1
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T131500Z
DTEND:20191113T134500Z
UID:b65a110b154047ba90c63ed3b846c14f
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Oral Posters 5 - Reproductive Endocrinology and Biology
CATEGORIES:
DESCRIPTION:13:20 | OP5.1 | Hypothalamic-pituitary-gonadal (HPG) axis suppression during basic military training in women despite increased adiposity and insulin resistance\n13:25 | OP5.2 | Profiling the expression and function of the truncated oestrogen receptor isoform ER46 in human endometrium\n13:30 | OP5.3 | Stress is implicated in programming metabolic disorders in the offspring of fructose-induced diabetic rats\n13:35 | OP5.4 | Kisspeptin as a novel biomarker for pregnancy complications\n
CLASS:PUBLIC
LOCATION:SfE Theatre
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T135000Z
DTEND:20191113T142000Z
UID:96556d5fe47b41509f5f9a0e3b2d6eb9
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Oral Posters 6 - Neuroendocrinology, Pituitary and Neoplasia
CATEGORIES:
DESCRIPTION:13:55 | OC6.1 | Extended TSS (guided by 11C-methionine PET + MRI (Met-PET/MRCR)) can be an effective treatment option for patients with persistent acromegaly due to previously deemed unresectable lateral disease\n14:00 | OC6.2 | Transcriptomic analyses reveal deregulation of focal adhesion pathway in Aip KO mice and AIP mutation positive human tumours\n14:05 | OP6.3 | JQ1 treatment significantly reduces POMC expression and ACTH secretion from the corticotrophinoma cell line, AtT20\n14:10 | OP6.4 | Urine steroid metabolomics as a novel diagnostic tool for recurrent adrenocortical carcinoma detection\n
CLASS:PUBLIC
LOCATION:SfE Theatre
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T142500Z
DTEND:20191113T151500Z
UID:98a8e74d8be84ea980a58552021464c8
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Endocrine Network: Bone and Calcium
CATEGORIES:
DESCRIPTION:
CLASS:PUBLIC
LOCATION:Meeting Room 14
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T142500Z
DTEND:20191113T151500Z
UID:b0b9f91d0a1842e49ec3503290748fe7
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Endocrine Network: Neuroendocrinology
CATEGORIES:
DESCRIPTION:
CLASS:PUBLIC
LOCATION:Meeting Room 6
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T142500Z
DTEND:20191113T151500Z
UID:6c77fccf51a843d18cadb770524fa2cd
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Endocrine Network: Endocrine Neoplasia Syndromes
CATEGORIES:
DESCRIPTION:
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T142500Z
DTEND:20191113T151500Z
UID:cb2b8b2b76a1484f823347936b6926fa
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Endocrine Network: Endocrine Consequences of Living with and Beyond Cancer
CATEGORIES:
DESCRIPTION:
CLASS:PUBLIC
LOCATION:Meeting room 10
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T142500Z
DTEND:20191113T151500Z
UID:78e846cfb5944988bcda072fe0682e50
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Endocrine Network: Thyroid
CATEGORIES:
DESCRIPTION:
CLASS:PUBLIC
LOCATION:Syndicate 3 & 4
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T142500Z
DTEND:20191113T151500Z
UID:5eb6c56d8d3f4485b896d7b50b0a4ff8
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Endocrine Network: Metabolic and Obesity
CATEGORIES:
DESCRIPTION:
CLASS:PUBLIC
LOCATION:Syndicate 1 & 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T142500Z
DTEND:20191113T151500Z
UID:083b3ea9ae2b48e294fe02aa4881c9d1
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Endocrine Network: Adrenal and Cardiovascular
CATEGORIES:
DESCRIPTION:
CLASS:PUBLIC
LOCATION:Meeting room 9
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T142500Z
DTEND:20191113T151500Z
UID:a52df153298b40f7974a5de443b7c06b
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Endocrine Network: Reproductive Endocrinology and Biology
CATEGORIES:
DESCRIPTION:
CLASS:PUBLIC
LOCATION:Meeting Room 8
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T151500Z
DTEND:20191113T164500Z
UID:91d1d4b71363447b90269655fc1a45b1
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Endocrinology in the UK:  Workforce, Standards, and Quality Improvement
CATEGORIES:
DESCRIPTION:15:15 | ROE1.1 | National standards and the specialised endocrinology Clinical Reference Group\n15:35 | ROE1.2 | GIRFT Getting it Right First Time in endocrinology\n15:55 | ROE1.3 | SfE Interdepartmental peer review\n16:15 | ROE1.4 | The 2018 diabetes and endocrinology consultant workforce survey (SfE/ABCD/DUK)\n16:35 | ROE1.5 | Q&A\n
CLASS:PUBLIC
LOCATION:Syndicate 3 & 4
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T151500Z
DTEND:20191113T164500Z
UID:373b3b3577494142a205824e951c7534
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Clinical Management Workshop 2: Hyperparathyroidism
CATEGORIES:
DESCRIPTION:15:15 | CMW2.1 | Management of primary hyperparathyroidism in pregnancy\n15:45 | CMW2.2 | Genetic testing in hyperparathyroidism across the ages- who to test and why\n16:15 | CMW2.3 | Challenges in recurrent hyperparathyroidism\n
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T151500Z
DTEND:20191113T164500Z
UID:7d7930bced384dada981bd5b93ec3844
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Basic Physiology Workshop: Imaging endocrinology from networks to organelles  
CATEGORIES:
DESCRIPTION:15:15 | BPW2.1 | In vivo imaging of endocrine cell networks\n15:45 | BPW2.2 | Spatial programming of GPCR signalling\n16:15 | BPW2.3 | High content imaging for monitoring signalling dynamics in single cells\n
CLASS:PUBLIC
LOCATION:Syndicate 1 & 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T165000Z
DTEND:20191113T172000Z
UID:0e8f92e86c084f22b05ca877440a2a3c
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Plenary 9: Society for Endocrinology Medal Lecture
CATEGORIES:
DESCRIPTION:16:50 | PL9 | Sex steroids and the endometrium: dynamics and disorders\n
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T172000Z
DTEND:20191113T173000Z
UID:7f63f64755bd4fc484771c99fbbe5e6a
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Prizes and Awards
CATEGORIES:
DESCRIPTION:
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
BEGIN:VEVENT
DTSTART:20191113T173000Z
DTEND:20191113T180000Z
UID:b5d1d476deb44d57934689689cc939bd
DTSTAMP:20191210T032401Z
LAST-MODIFIED:20191210T032401Z
SUMMARY:Plenary 10: Society for Endocrinology Jubilee Medal Lecture
CATEGORIES:
DESCRIPTION:17:30 | PL10 | Pituitary cells alive: hormone genes pulsing on and off\n
CLASS:PUBLIC
LOCATION:Auditorium 2
URL:
SEQUENCE:0
TRANSP:OPAQUE
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
END:VEVENT
END:VCALENDAR